FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
SPOTLIGHT: "Catching Up with Califf"
Demystifying Cronobacter and Actions FDA is Taking to Keep the Food Supply Safe
We’re encouraging industry and public health partners to help us build a robust library of genetic data for Cronobacter.
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![Blue technology themed image that depicts a world globe on the left side of the photo.](https://public4.pagefreezer.com:443/content/FDA/12-07-2023T11:51/https://www.fda.gov/files/styles/medium_3/public/Oncology%20RWE_1600x900_FINAL.png?itok=U-speO8m)
Facilitating Review of Real-World Data Studies: The Oncology QCARD Initiative
The Oncology QCARD Initiative was designed to facilitate effective communication between study sponsors and protocol reviewers.
![Image with blue abstract background with text aligned to the left that reads, "CDER's ARC Program: Accelerating Rare disease Cures."](https://public4.pagefreezer.com:443/content/FDA/12-07-2023T11:51/https://www.fda.gov/files/styles/medium_3/public/OND_ARC_WebBanner_1600x900px_230523_0.png?itok=LueYbnhZ)
Accelerating Rare disease Cures (ARC) Program Emerges as a Conduit for Empowering Rare Disease Stakeholders
The ARC Program strives to increase the number of treatments by promoting innovative scientific design, providing a deeper understanding of regulatory policies.
Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
---|